SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000921895-09-000700
Filing Date
2009-03-10
Accepted
2009-03-10 17:54:30
Documents
2
Effectiveness Date
2009-03-10

Document Format Files

Seq Description Document Type Size
1 defc14a07422003_03102009.htm DEFC14A 630704
2 mackenzie_logo.jpg GRAPHIC 4904
  Complete submission text file 0000921895-09-000700.txt   639572
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: DEFC14A | Act: 34 | File No.: 000-28272 | Film No.: 09670696
SIC: 2835 In Vitro & In Vivo Diagnostic Substances